VDR rs1801197: Understanding the BsmI Variant and Bone Health
The rs1801197 variant, commonly referred to as the BsmI polymorphism, is a genetic variation located within the vitamin D receptor (VDR) gene. It has been extensively studied for its potential associations with vitamin D metabolism, bone mineral density, and susceptibility to conditions like osteoporosis.
What each genotype means
Typical VDR BsmI profile
This genotype is often referred to as the 'BB' genotype in literature discussing the BsmI polymorphism. Some research suggests that individuals with this genotype may maintain better bone mineral density markers compared to other variants, though findings across different populations remain inconsistent. You should discuss any concerns regarding bone health or vitamin D status with your healthcare provider.
This genotype is common globally, though its specific frequency varies significantly depending on ancestral background.
Intermediate VDR BsmI profile
This genotype is often referred to as the 'Bb' genotype in scientific studies. Research into how this variant influences vitamin D metabolism and bone density has yielded mixed results, with some studies showing associations with bone status and others finding no significant impact. Please consult with your clinician to evaluate your personal bone health needs.
This heterozygous genotype is frequently observed in diverse populations worldwide.
Alternative VDR BsmI profile
This genotype is often referred to as the 'bb' genotype in research literature. While some studies investigate its potential link to bone mineral density and vitamin D receptor function, the evidence is not definitive and results often vary by study design and population. Always discuss your bone health and vitamin D levels with a qualified healthcare professional.
This genotype is common and found across many different ethnic and ancestral groups.
What is rs1801197?
The rs1801197 variant is a single nucleotide polymorphism (SNP) situated in the VDR gene, which is located on chromosome 12. In the scientific literature, this specific variant is frequently identified by the name BsmI, referring to the restriction enzyme used to detect it in early genetic studies. It is located in the 3' end of the VDR gene. Because this region does not code for the protein itself, researchers often consider it a non-functional marker. This means that while the variant itself may not directly change the structure of the vitamin D receptor protein, it might be in linkage disequilibrium with other, truly functional variations nearby. Essentially, rs1801197 often serves as a genetic signpost that helps scientists track inherited patterns within the VDR gene, rather than acting as the direct cause of a biological change.
The Role of the VDR Gene
The VDR gene provides instructions for creating the vitamin D receptor, a protein that acts as a nuclear receptor for calcitriol, the active form of vitamin D3. Once calcitriol binds to this receptor, the complex acts as a transcription factor, regulating the expression of various genes involved in calcium homeostasis and bone metabolism. By binding to specific vitamin D response elements in the DNA, the receptor helps the body maintain appropriate levels of calcium and phosphate, which are essential for building and maintaining strong, healthy bones. Because of its central role in these processes, the VDR gene is a primary candidate in research investigating the genetic basis of bone-related disorders. When the VDR system functions optimally, it supports skeletal integrity; however, disruptions in this pathway are linked to various metabolic bone diseases.
Research and Evidence Strength
The association between rs1801197 and bone health is a subject of extensive, yet often contradictory, research. Many studies have investigated whether this variant influences bone mineral density (BMD) or the risk of developing osteoporosis, particularly in postmenopausal women. While some meta-analyses have suggested potential links between VDR polymorphisms and bone density, others have found no significant association. The evidence is currently considered moderate and inconsistent across different populations. Researchers emphasize that osteoporosis is a complex, multifactorial condition influenced by a combination of genetics, aging, lifestyle, and environmental factors. Because the BsmI variant is likely non-functional, observed associations may vary depending on the specific genetic background of the population being studied. Consequently, it is not currently used as a definitive clinical tool for predicting individual bone health outcomes or diagnosing disease.
Population Frequency
The rs1801197 variant is considered a common polymorphism, meaning it is found at significant frequencies across diverse human populations. Because it is a common variant, it is widely distributed globally, though the specific distribution of its alleles can vary between different ancestral groups. This high frequency makes it a frequent subject of population-based genetic studies, as researchers can easily identify individuals with different genotypes to compare health outcomes. While the variant is common, the clinical relevance of these frequency differences remains a topic of ongoing investigation, as the impact of the variant appears to be highly dependent on the interaction between an individual's unique genetic makeup and their environmental exposure to vitamin D.
What This Information Means for You
Understanding your genotype for rs1801197 provides insight into your genetic architecture but does not serve as a medical diagnosis. Because the scientific evidence regarding this variant is mixed and its functional impact is not fully understood, it cannot be used to predict your personal risk of bone disease or your specific response to vitamin D supplementation. Genetic information should always be interpreted in the context of a comprehensive health assessment, including blood tests for vitamin D levels and bone density scans, if recommended by a healthcare professional. If you are concerned about your bone health or vitamin D status, consult with your physician or a registered dietitian. They can provide personalized guidance based on your clinical history and current health needs, rather than relying on a single genetic marker.
How common is this variant?
The rs1801197 variant is a common polymorphism found across diverse global populations, with varying allele frequencies observed between different ancestral groups.
Frequently asked questions
Is rs1801197 the same as BsmI?
Yes, rs1801197 is the official SNP identifier for the variant historically known as BsmI. The name BsmI comes from the restriction enzyme used in early laboratory methods to identify this specific genetic change.
Does this variant cause osteoporosis?
No, this variant does not cause osteoporosis. Osteoporosis is a complex, multifactorial disease, and while some studies have explored links between VDR variants and bone density, the evidence is inconsistent and not sufficient to establish a direct causal relationship.
Should I take more vitamin D if I have this variant?
You should not change your vitamin D intake based on this genetic variant. Always discuss your vitamin D levels and any potential supplementation with your healthcare provider, who can assess your needs through blood testing.
Can I use this test to predict my bone fracture risk?
No, this genetic variant is not a reliable tool for predicting individual fracture risk. Bone health is determined by many factors, including age, lifestyle, diet, and overall medical history, which are far more predictive than this single SNP.
Sources & further reading
Educational information only, last refreshed 9/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801197?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VDR
Variant in the promoter region (Cdx2 site) of the vitamin D receptor gene associated with altered intestinal calcium absorption and bone mineral density.
The Cdx2 promoter polymorphism alters vitamin D receptor gene transcription, modulating intestinal calcium absorption and bone mineral density.
Common polymorphism (TaqI variant) in the vitamin D receptor affecting mRNA stability and bone mineral density.
Known as the Taql polymorphism, this variant alters vitamin D receptor mRNA stability and modulates dietary calcium absorption and skeletal responsiveness.
Variant in the vitamin D receptor promoter (Cdx-2 binding site) associated with altered intestinal calcium absorption and bone mineral density predisposition.
Also known as the Cdx2 binding-site polymorphism in the VDR promoter, influencing intestinal calcium absorption and bone mineral density traits.